Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
28.52
+0.36 (1.28%)
May 4, 2026, 4:00 PM EDT - Market closed
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.45 billion as of May 4, 2026. Its market cap has increased by 1.89% in one year.
Market Cap
1.45B
Enterprise Value
1.02B
1-Year Change
1.89%
Ranking
Category
Stock Price
$28.52
Market Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from $1.80B to $1.45B, a decrease of -19.28%. That is a compound annual growth rate of -4.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 1.45B | -17.34% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maze Therapeutics | 1.50B |
| Biohaven | 1.45B |
| Immatics | 1.45B |
| Precigen | 1.44B |
| Bicara Therapeutics | 1.42B |
| MBX Biosciences | 1.42B |
| Wave Life Sciences | 1.41B |
| Iovance Biotherapeutics | 1.40B |